Pharmaceutical Grade API Prucalopride Succinate
You are here: Home » Products » API » Endocrine APIS » Prucalopride Succinate » Pharmaceutical Grade API Prucalopride Succinate

loading

Pharmaceutical Grade API Prucalopride Succinate

CAS No.: 179474-85-2
Formula: C22H32ClN3O7
Type: Pharmaceutical API
Appearance: Powder
Certificate: GMP, COPP, WC, DMF
Shelf Life 2 years
Quality Standard CP, EP, JP, USP
Assay 98.0%-102.0%
Chemical Name 4-amino-5-chloro-N-[1-(3-methoxypropyl)piperidin-4-yl]-2,3-dihydro-1-benzofuran-7-carboxamide;butanedioic acid
Availability:
Quantity:
facebook sharing button
twitter sharing button
line sharing button
wechat sharing button
linkedin sharing button
pinterest sharing button
whatsapp sharing button
sharethis sharing button

Product Description

Prucalopride Succinateis is a dihydrobenzofurancarboxamide compound that is a selective and high-affinity serotonin (5-HT4) receptor agonist with prokinetic activity in vitro and in vitro studies showing that prucalopric enhances the peristaltic reflex box in the gastrointestinal tract through 5-HT4 receptor activation.


Function

1.Serotonin 5-HT4 Receptor Agonism: Serotonin is a neurotransmitter that plays various roles in the body, including the regulation of gastrointestinal motility. Prucalopride acts as a selective agonist of the serotonin 5-HT4 receptors in the colon. By activating these receptors, Prucalopride stimulates the release of acetylcholine, which enhances the contractions of the smooth muscles in the colon, leading to increased bowel movements.

2.Treatment of Chronic Idiopathic Constipation: Chronic idiopathic constipation (CIC) is a common gastrointestinal disorder characterized by infrequent and difficult bowel movements. It is considered "idiopathic" because the exact cause of the condition is not known. Prucalopride is indicated for the treatment of CIC in adults who have not responded adequately to other laxatives or treatments.

Package

5.00kg/bag/drum, 5.00kg/bag, 2 bags/drum or according to customer’s requirements.



Related News

content is empty!

Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong Province, with a registered capital of 60 million yuan.

QUICK LINKS

PRODUCT CATEGORY

Copyright © 2023 Shandong Loncom Pharmaceutical Co., Ltd. All Rights Reserved. Sitemap | Privacy Policy
Supported by leadong.com
Contact Us